NUS researchers have developed a new anti-cancer drug that have less toxic effects to the kidneys. It works like a 'magic bullet' that is delivered directly to the mitochondria. Such targeted approach reduces the drug's interactions with other tissues, minimising side effects and lower the risk of patients developing resistance to anti-cancer drugs.